HEADER VIRAL PROTEIN 25-MAY-15 5BN0 TITLE A NEW HIV FUSION PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN GP160; COMPND 3 CHAIN: C, D; COMPND 4 FRAGMENT: UNP RESIDUES 627-661; COMPND 5 SYNONYM: ENDOGENOUS RETROVIRUS GROUP K MEMBER 113 ENV POLYPROTEIN, COMPND 6 ENDOGENOUS RETROVIRUS GROUP K MEMBER 13-1 ENV POLYPROTEIN,ENDOGENOUS COMPND 7 RETROVIRUS GROUP K MEMBER 18 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS COMPND 8 GROUP K MEMBER 19 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K COMPND 9 MEMBER 21 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K MEMBER 24 ENV COMPND 10 POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K MEMBER 25 ENV POLYPROTEIN, COMPND 11 ENDOGENOUS RETROVIRUS GROUP K MEMBER 6 ENV POLYPROTEIN,ENDOGENOUS COMPND 12 RETROVIRUS GROUP K MEMBER 7 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS COMPND 13 GROUP K MEMBER 9 ENV POLYPROTEIN,ENVELOPE GLYCOPROTEIN GP160; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: (ACE) IS ACETYL MODIFICATION OF THE N TERMINAL; COMPND 16 MOL_ID: 2; COMPND 17 MOLECULE: ENVELOPE GLYCOPROTEIN; COMPND 18 CHAIN: N, B, E; COMPND 19 FRAGMENT: UNP RESIDUES 35-70; COMPND 20 ENGINEERED: YES; COMPND 21 MOL_ID: 3; COMPND 22 MOLECULE: ENVELOPE GLYCOPROTEIN GP160; COMPND 23 CHAIN: A; COMPND 24 FRAGMENT: UNP RESIDUES 627-661; COMPND 25 SYNONYM: ENDOGENOUS RETROVIRUS GROUP K MEMBER 113 ENV POLYPROTEIN, COMPND 26 ENDOGENOUS RETROVIRUS GROUP K MEMBER 13-1 ENV POLYPROTEIN,ENDOGENOUS COMPND 27 RETROVIRUS GROUP K MEMBER 18 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS COMPND 28 GROUP K MEMBER 19 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K COMPND 29 MEMBER 21 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K MEMBER 24 ENV COMPND 30 POLYPROTEIN,ENDOGENOUS RETROVIRUS GROUP K MEMBER 25 ENV POLYPROTEIN, COMPND 31 ENDOGENOUS RETROVIRUS GROUP K MEMBER 6 ENV POLYPROTEIN,ENDOGENOUS COMPND 32 RETROVIRUS GROUP K MEMBER 7 ENV POLYPROTEIN,ENDOGENOUS RETROVIRUS COMPND 33 GROUP K MEMBER 9 ENV POLYPROTEIN,ENVELOPE GLYCOPROTEIN GP160; COMPND 34 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 8 ORGANISM_TAXID: 11676; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 12 ORGANISM_TAXID: 11676 KEYWDS INHIBITOR, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE REVDAT 1 25-MAY-16 5BN0 0 JRNL AUTH Y.XUE JRNL TITL A NEW HIV FUSION PEPTIDE INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.6.4_486 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 4994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.272 REMARK 3 R VALUE (WORKING SET) : 0.271 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 247 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 3.5265 - 2.8000 0.95 2397 131 0.2411 0.2488 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.30 REMARK 3 B_SOL : 21.06 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.490 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.610 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.14340 REMARK 3 B22 (A**2) : -9.20570 REMARK 3 B33 (A**2) : -12.88030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.69220 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 1796 REMARK 3 ANGLE : 1.155 2425 REMARK 3 CHIRALITY : 0.074 272 REMARK 3 PLANARITY : 0.003 315 REMARK 3 DIHEDRAL : 18.359 677 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BN0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209936. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11921 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 26.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 2.270 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CALCIUM CHLORIDE 0.1 M SODIUM REMARK 280 ACETATE PH 4.6 15 %PEG 400, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.57500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.17000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.57500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.17000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -94.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, N, A, B, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE N 580 REMARK 465 LEU N 581 REMARK 465 LEU B 581 REMARK 465 LEU D 660 REMARK 465 LEU D 661 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU D 654 O HOH D 701 2.09 REMARK 500 O GLN E 577 O ILE E 580 2.18 REMARK 500 OG1 THR N 569 O HOH N 601 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 660 CA - CB - CG ANGL. DEV. = 15.1 DEGREES REMARK 500 LEU A 661 CA - CB - CG ANGL. DEV. = -21.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 660 -77.94 -56.96 REMARK 500 REMARK 500 REMARK: NULL DBREF 5BN0 C 627 661 UNP B2CPZ5 B2CPZ5_9HIV1 627 661 DBREF 5BN0 N 546 581 UNP Q1HMR5 Q1HMR5_9HIV1 35 70 DBREF 5BN0 A 627 661 UNP B2CPZ5 B2CPZ5_9HIV1 627 661 DBREF 5BN0 B 546 581 UNP Q1HMR5 Q1HMR5_9HIV1 35 70 DBREF 5BN0 D 627 661 UNP B2CPZ5 B2CPZ5_9HIV1 627 661 DBREF 5BN0 E 546 581 UNP Q1HMR5 Q1HMR5_9HIV1 35 70 SEQADV 5BN0 ACE C 625 UNP B2CPZ5 EXPRESSION TAG SEQADV 5BN0 LEU C 626 UNP B2CPZ5 EXPRESSION TAG SEQADV 5BN0 LEU A 626 UNP B2CPZ5 EXPRESSION TAG SEQADV 5BN0 ACE D 625 UNP B2CPZ5 EXPRESSION TAG SEQADV 5BN0 LEU D 626 UNP B2CPZ5 EXPRESSION TAG SEQRES 1 C 37 ACE LEU THR TRP MET GLU TRP ASP ARG GLU ILE ASN ASN SEQRES 2 C 37 TYR THR SER LEU ILE HIS SER LEU ILE GLU GLU SER GLN SEQRES 3 C 37 ASN GLN GLN GLU LYS ASN GLU GLN GLU LEU LEU SEQRES 1 N 36 SER GLY ILE VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA SEQRES 2 N 36 ILE GLU ALA GLN GLN HIS LEU LEU GLN LEU THR VAL TRP SEQRES 3 N 36 GLY ILE LYS GLN LEU GLN ALA ARG ILE LEU SEQRES 1 A 36 LEU THR TRP MET GLU TRP ASP ARG GLU ILE ASN ASN TYR SEQRES 2 A 36 THR SER LEU ILE HIS SER LEU ILE GLU GLU SER GLN ASN SEQRES 3 A 36 GLN GLN GLU LYS ASN GLU GLN GLU LEU LEU SEQRES 1 B 36 SER GLY ILE VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA SEQRES 2 B 36 ILE GLU ALA GLN GLN HIS LEU LEU GLN LEU THR VAL TRP SEQRES 3 B 36 GLY ILE LYS GLN LEU GLN ALA ARG ILE LEU SEQRES 1 D 37 ACE LEU THR TRP MET GLU TRP ASP ARG GLU ILE ASN ASN SEQRES 2 D 37 TYR THR SER LEU ILE HIS SER LEU ILE GLU GLU SER GLN SEQRES 3 D 37 ASN GLN GLN GLU LYS ASN GLU GLN GLU LEU LEU SEQRES 1 E 36 SER GLY ILE VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA SEQRES 2 E 36 ILE GLU ALA GLN GLN HIS LEU LEU GLN LEU THR VAL TRP SEQRES 3 E 36 GLY ILE LYS GLN LEU GLN ALA ARG ILE LEU HET ACE C 625 3 HET ACE D 625 3 HETNAM ACE ACETYL GROUP FORMUL 1 ACE 2(C2 H4 O) FORMUL 7 HOH *29(H2 O) HELIX 1 AA1 THR C 627 GLU C 659 1 33 HELIX 2 AA2 GLY N 547 ARG N 579 1 33 HELIX 3 AA3 THR A 627 LEU A 661 1 35 HELIX 4 AA4 GLY B 547 ILE B 580 1 34 HELIX 5 AA5 THR D 627 GLU D 659 1 33 HELIX 6 AA6 GLY E 547 ILE E 580 1 34 LINK C ACE C 625 N LEU C 626 1555 1555 1.33 LINK C ACE D 625 N LEU D 626 1555 1555 1.33 CRYST1 77.150 52.340 60.260 90.00 117.46 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012962 0.000000 0.006736 0.00000 SCALE2 0.000000 0.019106 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018702 0.00000 HETATM 1 C ACE C 625 -17.970 12.295 28.701 1.00 14.75 C HETATM 2 O ACE C 625 -18.579 13.358 28.804 1.00 17.65 O HETATM 3 CH3 ACE C 625 -16.616 12.097 29.375 1.00 11.03 C